官方服务：
资源简介：
Full data for 2022
应用场景：
创建时间：
2022-08-18
相关数据集
Supplementary Material for: Postmarketing Safety of Temozolomide: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System
Abstract Background: Temozolomide is a widely used chemotherapy agent for the treatment of malignant gliomas and other brain tumors. Despite its established therapeutic benefits, there is an ongoing
DataCite Commons2024-12-05 更新150
Additional file 2 of Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study
Additional file 2. Summary table of adverse events
DataCite Commons2024-08-13 更新30
MMRV vaccine safety: A comprehensive analysis of adverse events recorded among pediatric populations
Measles, mumps, rubella, and varicella (MMRV) vaccines are widely used in global immunization programs, but safety data on their administration in children remain limited. We analyzed adverse events f
NIAID Data Ecosystem20
rhGH-FAERS-Research Data
本研究所使用的数据来源于 美国FDA不良事件报告系统（FAERS） 的公开季度数据文件（时间范围：XXXX年X月至XXXX年X月），所有原始数据均可在FDA官方网站（https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting
DataCite Commons2025-04-07 更新70
Retrospective AEs found during AE form review.
Retrospective AEs found during AE form review.
Figshare2019-06-10 更新20
